FAKTOR OPTIONSSCHEIN - IPSEN | Real-time BOERSE MUENCHEN 08:25:53 2024-05-30 am EDT | ||
| 0.36 EUR | +1.12% |
|
| Current month | -74.01% | ||
| 1 month | -78.29% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
IPSEN
Latest news about IPSEN
More news
| Date | Price | Change |
|---|---|---|
| 24-05-30 | 0.36 | +1.12% |
| 24-05-29 | 0.356 | 0.00% |
| 24-05-28 | 0.356 | +16.34% |
| 24-05-27 | 0.306 | +53.00% |
| 24-05-24 | 0.2 | -20.00% |
Real-time BOERSE MUENCHEN
Last update May 30, 2024 at 08:25 am EDT
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | IPSEN |
| Issuer | Goldman Sachs |
| WKN | GG6F1W |
| ISIN | DE000GG6F1W9 |
| Date issued | 2024-04-03 |
| Strike | 126.7 € |
| Maturity | Unlimited |
| Parity | 23.92 : 1 |
| Emission price | 10 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 9.32 € |
|---|---|
| Lowest since issue | 0.2 € |
| Spread | 0.01 € |
| Spread % | 2.86% |
Company Profile
Ipsen specialises in the research, development, manufacture and marketing of specialty medicines. Net sales by therapeutic area break down as follows:
- oncology (75.2%);
- neuroscience (21.1%);
- rare diseases (3.7%).
At the end of 2023, the group had 4 research and development centres located in France, the United Kingdom, the United States and China, and 4 manufacturing sites worldwide.
Net sales are distributed geographically as follows: Europe (40.2%), North America (33.3%) and other (26.5%).
Sector
-
Consensus: Ipsen
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
16
Last Close Price
120
EUR
Average target price
126.4
EUR
Spread / Average Target
+5.33%
- Stock Market
- Certificates
- Certificat
